Latest news
Dr Akkus on Making Second-Line HCC Decisions Without Randomized Data - OncLiveOncLive · Mon, 10 Aug 2026 15:56:15 GMTLeads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in First-Line Hepatocellular Carcinoma Following Positive Efficacy Signals - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 01:13:02 GMT